RGRX

REGENERX BIOPHARMS INC by RegeneRx Biopharmaceuticals, Inc. (RGRX)

About REGENERX BIOPHARMS INC by RegeneRx Biopharmaceuticals, Inc. (RGRX)

RegeneRx Biopharmaceuticals, Inc. engages in the development of a novel therapeutic peptide, Thymosin beta 4 for tissue and organ protection, repair, and regeneration. Its product pipeline includes RGN-259, RGN-352, and RGN-137. The company was founded by Allan L. Goldstein on May 13, 1982 and is headquartered in Glen Echo, MD.

Details

Daily high
$0.17
Daily low
$0.17
Price at open
$0.17
52 Week High
$0.17
52 Week Low
$0.00
Market cap
259,000
Dividend yield
0.00%
Volume
835
Avg. volume
66
P/E ratio
--

REGENERX BIOPHARMS INC by RegeneRx Biopharmaceuticals, Inc. News

Details

Daily high
$0.17
Daily low
$0.17
Price at open
$0.17
52 Week High
$0.17
52 Week Low
$0.00
Market cap
259,000
Dividend yield
0.00%
Volume
835
Avg. volume
66
P/E ratio
--